Claire Nader, RD brings a nutrition-centered approach to weight management that pays close attention to how medication and daily habits intersect. Her work speaks directly to one of the more nuanced realities of modern obesity care: even with a medication like Zepbound (tirzepatide), progress can stall. Rather than treating that slowdown as a mystery, the focus is on understanding the science behind tirzepatide, exploring why it may not be working as expected, and identifying practical ways to regain momentum.
That approach is notably grounded in the details that often shape outcomes. Nutrition is not treated as an afterthought to medication, but as an essential part of how weight-loss treatment functions in real life. Questions around food choices, weight-loss expectations, and even dosage timing are part of a broader effort to understand why tirzepatide-related results may have slowed.
The emphasis is on clear, usable guidance that helps translate medical treatment into sustainable day-to-day progress. Accessibility is also part of the model. Through Fay, clients are connected with registered dietitians, and insurance is handled directly to make nutrition care easier to access and more affordable.
In practice, that creates a straightforward path into evidence-based support for people trying to make sense of weight loss on tirzepatide and seeking informed, practical nutrition guidance rather than generic advice. The overall character of the practice is pragmatic and educational: science-forward, attentive to the realities of medication-assisted weight loss, and committed to helping clients move from frustration toward a more workable plan.
Claire Nader, RD
1100 N Dearborn St
Chicago, IL 60610
Is this your business?